Skinvive by Juvéderm Targets Neck Lines in New FDA Filing
If approved, Skinvive by Juvéderm will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines.
If approved, Skinvive by Juvéderm will be the first hyaluronic acid injectable treatment option aiming to reduce neck lines.
New framework aims to address inconsistencies in how skin quality is described during aesthetic consultations.